123I Radiolabeled 3BNC117

Clinical trial NCT03468582 · COMPLETED

Trial details

NCT number: NCT03468582
Sponsor: University of Lausanne Hospitals
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2018-02-08
Primary completion: 2020-01-28
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.